is tirzepatide not available anymore vs Semaglutide: What You Need to Know Tirzepatide for Medical Weight Loss

Weight-loss wonder drug Mounjaro/Zepbound shrinks breast cancer tumors Date: July 15, 2025 Source: The Endocrine Society Summary: A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors

And those lucky enough to find them in pharmacies are often forced to pay for the drug, which can run more than $1,000 per month, out-of-pocket because their insurers, like Simontons, refuse to cover them

This makes it an excellent choice for maintaining mental sharpness as you age

Energy levels and daily activities can usually be maintained normally during your first week on GLP-1 therapy